5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
BUY | BUY | BUY | SELL | SELL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 0.55▲ | 0.55▲ | 0.55▲ | 0.54▲ | 0.57▼ |
MA10 | 0.54▲ | 0.54▲ | 0.54▲ | 0.54▲ | 0.61▼ |
MA20 | 0.54▲ | 0.54▲ | 0.54▲ | 0.57▼ | 0.70▼ |
MA50 | 0.54▲ | 0.56▼ | 0.56▼ | 0.61▼ | 1.02▼ |
MA100 | 0.58▼ | 0.61▼ | 0.61▼ | 0.72▼ | N/A |
MA200 | 0.61▼ | 0.61▼ | 0.66▼ | 0.92▼ | N/A |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | 0.004▲ | 0.005▲ | 0.005▲ | 0.000▲ | 0.010▲ |
RSI | 55.543▲ | 52.819▲ | 52.634▲ | 44.310▼ | 39.449▼ |
STOCH | 83.192▲ | 83.192▲ | 89.520▲ | 37.005 | 20.657 |
WILL %R | -3.684▲ | -3.684▲ | -3.684▲ | -53.636 | -86.923▼ |
CCI | 100.063▲ | 103.658▲ | 105.089▲ | -24.093 | -91.340 |
Friday, February 14, 2025 09:20 AM
CRISPR's upcoming trial data and increasing demand for Casgevy drive Evercore's bullish outlook and a higher price target ...
|
Thursday, February 13, 2025 05:25 AM
Conduit Pharmaceuticals partners with Charles River to evaluate the efficacy of its lead programme in a pre-clinical lupus model, utilizing ...
|
Wednesday, February 12, 2025 04:30 AM
We are excited to collaborate with Biogen on litifilimab,” said Pablo Legorreta, Royalty Pharma’s founder and Chief Executive Officer. “Royalty Pharma offers tailored, win-win funding solutions for ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
18/02/25 | 0.5401 | 0.5799 | 0.52 | 0.551 | 88,933 |
14/02/25 | 0.55 | 0.56 | 0.525 | 0.56 | 152,356 |
13/02/25 | 0.52 | 0.5601 | 0.5115 | 0.54 | 117,701 |
12/02/25 | 0.5388 | 0.5388 | 0.50 | 0.5149 | 73,386 |
11/02/25 | 0.55 | 0.5598 | 0.5175 | 0.525 | 60,284 |
10/02/25 | 0.56 | 0.56 | 0.52 | 0.5461 | 79,557 |
07/02/25 | 0.5503 | 0.58 | 0.5211 | 0.539 | 62,492 |
06/02/25 | 0.58 | 0.58 | 0.5266 | 0.55 | 25,106 |
05/02/25 | 0.5141 | 0.58 | 0.5141 | 0.58 | 110,933 |
04/02/25 | 0.60 | 0.60 | 0.521 | 0.53 | 201,157 |
|
|
||||
|
|
||||
|
|